• Return to Headlines

Concert Pharmace Shares Up 28.4% Since SmarTrend's Buy Recommendation (CNCE)

By Amy Schwartz

SmarTrend identified an Uptrend for Concert Pharmace (NASDAQ:CNCE) on November 12th, 2019 at $7.57. In approximately 2 months, Concert Pharmace has returned 28.40% as of today's recent price of $9.72.

Concert Pharmace share prices have moved between a 52-week high of $17.83 and a 52-week low of $5.36 and are now trading 81% above that low price at $9.72 per share. Over the last five market days, the 200-day moving average (MA) has gone down 1% while the 50-day MA has advanced 2.5%.

Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company. The Company focuses on the use of deuterium to enhance the effects of approved drugs. Concert Pharmaceuticals offers its products throughout the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Concert Pharmace shares.

Log in and add Concert Pharmace (CNCE) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights concert pharmace

Ticker(s): CNCE